Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Allogene Therapeutics, Inc. (ALLO)
Sector: Healthcare; Industry: Biotechnology

Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is developing UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate, which is in Phase I clinical trials for the treatment of pediatric and adult patients with R/R CD19 positive B-cell ALL; ALLO-501, an anti-CD19 allogeneic CAR T cell product candidate that is in Phase I clinical trial for the treatment of R/R non-Hodgkin lymphoma; and ALLO-501A for the treatment R/R large B-cell lymphoma or transformed follicular lymphoma.

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-03-15 Amado Rafael EVP of R&D and CMO Sell 5,169 $7.71 $39,848 No
2021-10-01 Amado Rafael EVP of R&D and CMO Sell 11,507 $24.35 $280,185 No
2021-03-15 Amado Rafael EVP of R&D and CMO Sell 2,798 $38.05 $106,471 No
2020-10-07 Amado Rafael EVP of R&D and CMO Sell 16,538 $39.40 $651,515 No
2020-10-01 Amado Rafael EVP of R&D and CMO Sell 9,752 $36.37 $354,662 No

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.

Insider Smart

Carvana Co (CVNA) - One of the best timed insider buying in the crash is from GARCIA ERNEST C. II 10%-owner of CVNA. Bought at 45 and now with a 100%+ profit.